People's Republic of China (PRC) Pharmacopoeia (2000 edition) records that the fruiting bodies of Ganoderma lucidum (Ganoderma lucidum, Ganoderma lucidum) are legal Chinese herbal medicines; Previously, the Ministry of Health has also approved Ganoderma lucidum as a new food resource. In this way, Ganoderma lucidum has truly become a traditional Chinese medicine with homology of medicine and food, and has achieved the legal status of homology of medicine and food in China, whether as medicine or health food. In 2000, Ganoderma lucidum was included in American Herbal Pharmacopoeia and Therapeutic Summary published in the United States. So far, this book has included 65,438+00 kinds of Chinese medicines or herbs, and Ganoderma lucidum is one of them. It can be seen that the American medical community also attaches great importance to the medicinal value of Ganoderma lucidum.
Ganoderma lucidum belongs to fungal plants. According to its life history, it can be divided into three stages. After the fruiting body of Ganoderma lucidum matures, spores are scattered everywhere, and only 2% ~ 3% of spore powder can meet the environment suitable for its growth, then form mycelium and finally become fruiting body. Therefore, Ganoderma lucidum is composed of spore powder, mycelium and fruiting body in three different growth stages. Artificially cultivated Ganoderma lucidum fruiting body is cultivated by inoculating mycelium on wood or other culture materials, rather than directly cultivated by Ganoderma lucidum spores. As traditional Chinese medicine or healthy food, these three parts are all useful. However, in People's Republic of China (PRC) Pharmacopoeia (2000 edition), only the fruiting body of Ganoderma lucidum (Ganoderma lucidum, Ganoderma lucidum) is listed as a legal Chinese herbal medicine, while spore powder is not a legal Chinese herbal medicine.
Modern medical research has proved that Ganoderma lucidum contains many chemical components, among which polysaccharides, triterpenoids, peptides, adenosine, purine and other components are its main effective components. It is also proved that Ganoderma lucidum and its effective components have a wide range of pharmacological effects, such as immunomodulation, anti-tumor, anti-radiation and chemotherapy-induced damage, sedation, cardiotonic and anti-myocardial ischemia, liver protection, hypoglycemic, antioxidant and free radical scavenging, anti-aging and so on. Clinical studies have proved that Ganoderma lucidum preparation can be used to prevent and treat chronic bronchitis and asthma, coronary heart disease, dyslipidemia, neurasthenia, insomnia, hepatitis and diabetes, and as an auxiliary drug for tumor radiotherapy and chemotherapy.
On the basis of pharmacological and clinical research of Ganoderma lucidum, Chinese scholars put forward the role of Ganoderma lucidum in strengthening important organs and systems of human body, regulating neuroendocrine immune network of human body and promoting the stability of internal environment, that is, steady-state regulation. Regulating the balance of human body through "strengthening the body resistance and consolidating the constitution" is the basis of the health care effect of Ganoderma lucidum. The study on the chemical constituents and pharmacological effects of Ganoderma lucidum laid a good foundation for its clinical application, product development and product quality control.
At present, there are many kinds of Ganoderma lucidum products sold in the domestic market, including raw materials, pharmaceutical preparations, health foods and so on. And their effects are different, and they are often exaggerated and untrue. Therefore, the rational application and correct evaluation of the medicinal value of Ganoderma lucidum is still a top priority.
Generally speaking, Ganoderma lucidum can be used as a therapeutic drug for some diseases, and it can also be used as one of the comprehensive or auxiliary therapeutic drugs for more diseases. In addition, it can also be used for health care of sub-healthy people, especially middle-aged and elderly people.